Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.
Acknowledgment of Support
This activity is supported by educational grants from Incyte Corporation and Mallinckrodt Pharmaceuticals.
Cancer Summaries and Commentaries™: Updates from San Diego on the Treatment of GvHD
Release Date: December 23, 2020
Expiration Date: December 23, 2021
Activity Overview
This online activity is designed to update clinicians on data presented at the All-Virtual 62nd American Society of Hematology (ASH) Annual Meeting & Exposition, held December 5 to December 8, 2020, and will help facilitate critical assessment and clinical integration of new evidence. The activity reviews 6 abstracts from the 2020 ASH program that focus on graft-versus-host disease (GVHD). For each abstract, a text summary of key clinical data is accompanied by perspectives from expert thought leaders who provide insights into how clinicians can apply these findings to their clinical practice to improve patient care.
Acknowledgement of Commercial Support
This activity is supported by educational grants from Incyte Corporation and Mallinckrodt Pharmaceuticals.
Instructions for This Activity and Receiving Credit
You may immediately download your certificate. |
Target Audience
This educational activity is directed toward medical oncologists/hematologists and fellows who treat patients with GVHD. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of GVHD will be invited to participate.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Explain the study design and rationale of recent clinical trials for the prevention and treatment of GVHD
- Describe results from recent trials that have evaluated emerging approaches for the management of GVHD
- Evaluate recent evidence on novel therapeutic approaches for GVHD in the context of evolving treatment paradigms in the field
Faculty, Staff, and Planners’ Disclosures
In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Faculty

Deputy Director
Department of Stem Cell Transplantation
University Medical Center Hamburg
Germany
Associate Professor of Medicine
University of Hamburg
Germany
Disclosures: Francis A. Ayuk, MD, has no relevant financial relationships with commercial interests.

Medical Director, Stem Cell Transplantation
Dana-Farber Cancer Institute
Boston, MA
Associate Professor of Medicine
Harvard Medical School
Boston, MA
Disclosures: Consultant: Incyte, Omeros, Jazz, Genentech, Medsenic, Generon
The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
Login or Register to Start Activity
Please use the form below to Register or Log In to begin Activity.


